Satellite symposia are not part of the scientific program, but they are an important part of the annual meeting and are planned to meet the same standards of evidence, scientific rigor, and fair balance. Satellite symposia provide opportunities to learn about new and emerging clinical options not addressed in the scientific program. Explore the list of Satellite Symposia occurring at this year's Annual Scientific Meeting below. Some satellite symposia are available OnDemand in the HFSA Learning Center. Learn more >>
Friday, September 10
Easing the Burden of Hypertrophic Cardiomyopathy: Progress in Understanding & Addressing its Pathophysiology
Friday, September 10 | 7:30 PM – 8:30 PM | Colorado B
Supported through an educational grant by Bristol Myers Squibb
Saturday, September 11
Bridging the Iron Deficiency Chasm in Heart Failure: The Revolutionary Role of Intravenous Iron in Optimizing Outcomes
Saturday, September 11 | 8:15 AM – 9:30 AM | Colorado B
Supported by an independent educational grant from American Regent
Cardiac Amyloidosis: What Heart Failure Clinicians Need to Know
Saturday, September 11 | 8:15 AM – 9:30 AM | Colorado C | OnDemand Post-Meeting
Supported by unrestricted education grants provided by the Amyloidosis Research Consortium, Eidos Therapeutics, Ionis Pharmaceuticals and Pfizer.
Demystifying Pharmacologic Therapy in HFrEF: Pivotal Opportunities to Improve Patient Outcomes
Saturday, September 11 | 7:30 PM – 9:00 PM | Colorado B | OnDemand Post Meeting
Supported by an independent educational grant from Vifor Pharma
Improving Pump Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Challenges and Opportunities
Saturday, September 11 | 7:30 PM – 9:00 PM | Colorado C | OnDemand Post Meeting
Supported by an independent educational grant from Cytokinetics Incorporated
Sunday, September 12
Expert Perspectives on SGLT2 Inhibitors: Reviewing Their Role in Type 2 Diabetes, Heart Failure and Chronic Kidney Disease
Sunday, September 12 | 6:45 AM - 7:45 AM | Colorado A | OnDemand Post-Meeting
Supported by an independent medical education grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company
SGLT2 Inhibition and Heart Failure: Translating the Evidence to Clinical Practice
Sunday, September 12 | 5:00 PM - 6:30 PM | Colorado B | OnDemand Post-Meeting
Supported by an educational grant from AstraZeneca Pharmaceuticals
Emergence of Novel Therapies for the Management of HFrEF
Sunday, September 12 | 5:00 PM - 6:30 PM | Colorado C
Supported by an educational grant from Merck & Co., Inc.